AXOVANT SCIENCES LTD ORD (AXON) was Initiated by Leerink Partners to “Outperform” and the brokerage firm has set the Price Target at $22. Leerink Partners advised their investors in a research report released on Jun 7, 2016.
On the company’s financial health, AXOVANT SCIENCES LTD ORD reported $-0.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Nov 2, 2015. Analyst had a consensus of $-0.16.During the same quarter in the previous year, the company posted $-0.45 EPS.
AXOVANT SCIENCES LTD ORD closed down -0.24 points or -1.82% at $12.98 with 2,48,442 shares getting traded on Friday. Post opening the session at $13.23, the shares hit an intraday low of $12.59 and an intraday high of $13.265 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Mar 14, 2016, Mark Altmeyer (Pres&Chief Commercial Officer) purchased 2,300 shares at $11.14 per share price.